Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/000596
CTRI/2010/091/000596
Recruiting
Phase 3

A clinical trial to study the extended safety and efficacy of dendritic cell-based cancer immunotherapy in stage III recurrent serous type ovarian cancer or stage IV ovarian cancer having serum CA 125 positivity.

Instutute of Cellular Therapies Pvt. Ltd.0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Instutute of Cellular Therapies Pvt. Ltd.
Enrollment
50
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Instutute of Cellular Therapies Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • •Adult females
  • •Age between 18yrs to 65yrs
  • •Serous ovarian cancer with CA125 positivity
  • •In Remission
  • •Performance status between 0 to 3 (ECOG)

Exclusion Criteria

  • •Autoimmune disease
  • •Liver disease having serum bilirubin more than 3mg%
  • •Renal disease having raised serum creatinine more than \>2mg%
  • •HIV positive status

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.Severe nasal deformity in orofacial cleft, that needs nasal augmentation and nasal tip correction
JPRN-UMIN000017734The University of Tokyo Hospital2
Recruiting
Phase 1
SHED for cerebral palsy
JPRN-jRCTb040230042Sato Yoshiaki3
Completed
Not Applicable
Exploratory trial for the confirmation of safety to the mask using ingredient of cinnamon bark and ginger extractio20 years or older adult medical staff who have finished the influenza vaccination of this season
JPRN-UMIN000014540Department of Japanese-Oriental l(Kampo) Medicine,Graduate School of Medicine, Chiba University50
Not yet recruiting
Not Applicable
Investigating the efficacy and safety of a prototype ultra-low-cost insulin pump (ULCIP)
ACTRN12623001288617niversity of Canterbury6
Active, not recruiting
Phase 3
Clinical trial for evaluation of efficacy and safety of the therapeutic device(RP-14) based on disinfection technique utilizing photolysis of hydrogen peroxide for moderate-severe chronic periodontitis
JPRN-UMIN000016791Tohoku University Graduate School of Dentistry55